These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27028131)

  • 41. Intensity of Glycemic Control Affects Long-Term Survival After Coronary Artery Bypass Graft Surgery.
    Robich MP; Iribarne A; Leavitt BJ; Malenka DJ; Quinn RD; Olmstead EM; Ross CS; Sawyer DB; Klemperer JD; Clough RA; Kramer RS; Baribeau YR; Sardella GL; DiScipio AW;
    Ann Thorac Surg; 2019 Feb; 107(2):477-484. PubMed ID: 30273572
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ABC goal achievement predicts microvascular but not macrovascular complications over 6-years in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study.
    Bjornstad P; Maahs DM; Rewers M; Johnson RJ; Snell-Bergeon JK
    J Diabetes Complications; 2014; 28(6):762-6. PubMed ID: 25270733
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
    Chiarelli F; Spagnoli A; Basciani F; Tumini S; Mezzetti A; Cipollone F; Cuccurullo F; Morgese G; Verrotti A
    Diabet Med; 2000 Sep; 17(9):650-6. PubMed ID: 11051284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heterogeneous long-term trajectories of glycaemic control in type 1 diabetes.
    Miller RG; Orchard TJ; Onengut-Gumuscu S; Chen WM; Rich SS; Costacou T
    Diabet Med; 2021 Aug; 38(8):e14545. PubMed ID: 33605492
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.
    Nitta Y; Tahara N; Tahara A; Honda A; Kodama N; Mizoguchi M; Kaida H; Ishibashi M; Hayabuchi N; Ikeda H; Yamagishi S; Imaizumi T
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1172-82. PubMed ID: 24229770
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mean HbA
    Forbes A; Murrells T; Mulnier H; Sinclair AJ
    Lancet Diabetes Endocrinol; 2018 Jun; 6(6):476-486. PubMed ID: 29674135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study.
    Munkhaugen J; Hjelmesæth J; Otterstad JE; Helseth R; Sollid ST; Gjertsen E; Gullestad L; Perk J; Moum T; Husebye E; Dammen T
    BMC Cardiovasc Disord; 2018 Aug; 18(1):160. PubMed ID: 30075751
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synergistic effect of smoking with genetic variants in the AMPKα1 gene on the risk of coronary artery disease in type 2 diabetes.
    Ma X; Zhang J; Deng R; Ding S; Gu N; Guo X
    Diabetes Metab Res Rev; 2014 Sep; 30(6):483-8. PubMed ID: 24395629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy.
    van Ark J; Hammes HP; van Dijk MC; Lexis CP; van der Horst IC; Zeebregts CJ; Vervloet MG; Wolffenbuttel BH; van Goor H; Hillebrands JL
    Cardiovasc Diabetol; 2013 Aug; 12():116. PubMed ID: 23945089
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of Diabetic Status and Glycemic Control With Ischemic and Bleeding Outcomes in Patients With Stable Coronary Artery Disease: The 5-Year CORONOR Registry.
    Lemesle G; Meurice T; Tricot O; Lamblin N; Bauters C
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glycaemic control and the risk of mortality in elderly type 2 diabetic patients (ZODIAC-20).
    van Hateren KJ; Landman GW; Kleefstra N; Drion I; Groenier KH; Houweling ST; Bilo HJ
    Int J Clin Pract; 2011 Apr; 65(4):415-9. PubMed ID: 21401830
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Haptoglobin genotype modulates the relationships of glycaemic control with cognitive function in elderly individuals with type 2 diabetes.
    Guerrero-Berroa E; Ravona-Springer R; Heymann A; Schmeidler J; Levy A; Leroith D; Beeri MS
    Diabetologia; 2015 Apr; 58(4):736-44. PubMed ID: 25628235
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Better glycaemic control and risk reduction of diabetic complications in Type 2 diabetes: comparison with the DCCT.
    Molyneaux LM; Constantino MI; McGill M; Zilkens R; Yue DK
    Diabetes Res Clin Pract; 1998 Nov; 42(2):77-83. PubMed ID: 9886743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in out-patient diabetic patients at Kenyatta National Hospital.
    Otieno FC; Ng'ang'a L; Kariuki M
    East Afr Med J; 2002 Sep; 79(9):491-5. PubMed ID: 12625691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study.
    Fährmann ER; Adkins L; Loader CJ; Han H; Rice KM; Denvir J; Driscoll HK
    Diabetes Res Clin Pract; 2015 Feb; 107(2):280-9. PubMed ID: 25467622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Association of Lipoprotein(a) Plasma Levels With Prevalence of Cardiovascular Disease and Metabolic Control Status in Patients With Type 1 Diabetes.
    Littmann K; Wodaje T; Alvarsson M; Bottai M; Eriksson M; Parini P; Brinck J
    Diabetes Care; 2020 Aug; 43(8):1851-1858. PubMed ID: 31862789
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The relevance of persistent C-peptide secretion in type 1 (insulin-dependent) diabetes mellitus to glycaemic control and diabetic complications.
    Winocour PH; Jeacock J; Kalsi P; Gordon C; Anderson DC
    Diabetes Res Clin Pract; 1990 Apr; 9(1):23-35. PubMed ID: 2351037
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does the Concentration of Oxidative and Inflammatory Biomarkers Differ by Haptoglobin Genotype in Type 1 Diabetes?
    Costacou T; Evans RW; Orchard TJ
    Antioxid Redox Signal; 2015 Dec; 23(18):1439-44. PubMed ID: 26114833
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Random blood glucose may be used to assess long-term glycaemic control among patients with type 2 diabetes mellitus in a rural African clinical setting.
    Rasmussen JB; Nordin LS; Rasmussen NS; Thomsen JA; Street LA; Bygbjerg IC; Christensen DL
    Trop Med Int Health; 2014 Dec; 19(12):1515-9. PubMed ID: 25294180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial.
    Heimbürger SMN; Hoe B; Nielsen CN; Bergmann NC; Hartmann B; Holst JJ; Vilsbøll T; Dejgaard TF; Christensen MB; Knop FK
    Diabetologia; 2021 Nov; 64(11):2425-2431. PubMed ID: 34405256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.